No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BIIB250103C172500
- 0.05
- 0.000.00%
15min DelayClose Jan 2 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume2 Open Interest172.50Strike Price0.00Turnover177.54%IV15.03%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0151Delta0.0040Gamma3000.00Leverage Ratio-0.3508Theta0.0000Rho45.28Eff Leverage0.0020Vega
Intraday
- 5D
- Daily
News
Biogen Shares Lower After Piper Sandler Downgrade
17 Analysts Assess Biogen: What You Need To Know
Biogen Price Target Cut to $138.00/Share From $315.00 by Piper Sandler
Biogen Analyst Ratings
Express News | Piper Sandler has downgraded Biogen's rating to neutral.
These Battered S&P 500 Stocks Could Be Ripe for a Turnaround in 2025